Doctor profile · Federal record

Dr. Lindsay Kelmenson, MD

Rheumatology Physician (CMS: Rheumatology) · Hoover, AL

  • NPI 1457647935
  • Accepts Medicare
  • MIPS 88.3 / 100 · 2023
  • 15 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
5356 Stadium Trace Pkwy Ste 200
Hoover, AL 352445610
(205) 444-4858
fax (205) 444-4856

Credentials & registration

NPPES · NUCC
NPI registered
June 2011 — 15 yrs on file
Profile last updated
June 15, 2021
Year of graduation
2011 — 15 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Alabama #36800

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1457647935. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
13,666
Distinct HCPCS
10
Medicare allowed
$525,408
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 7,600 13 $42
J0897 Injection, denosumab, 1 mg 5,040 55 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 297 162 $118
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 266 63 $64
96413 Administration of chemotherapy into vein, 1 hour or less 140 23 $115
96375 Injection of additional new drug or substance into vein 104 17 $14
99215 Established patient office or other outpatient visit, 40-54 minutes 73 53 $160
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 61 14 $4
J1030 Injection, methylprednisolone acetate, 40 mg 35 19 $8
99205 New patient office or other outpatient visit, 60-74 minutes 32 32 $197

In context: peer comparison

Among 1 peers in Hoover Rheumatology Physician, average services per provider: 1,242. This provider delivers 11× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,539
Transactions
165
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 30 $715.26
Amgen INC. 31 $541.56
Ucb, INC. 21 $334.09
Janssen Biotech, INC. 11 $261.44
Lilly USA, LLC 15 $256.86
Pfizer INC. 15 $213.43
Novartis Pharmaceuticals Corporation 9 $162.11
Boehringer Ingelheim Pharmaceuticals, INC. 5 $125.07
Ani Pharmaceuticals, INC. 4 $118.95
AstraZeneca Pharmaceuticals Lp 5 $101.79
E.R. Squibb & Sons, L.L.C. 4 $85.81
GlaxoSmithKline, LLC. 4 $84.21
Fresenius Kabi USA, LLC 4 $82.66
Mallinckrodt Hospital Products INC. 3 $80.16
Radius Health, INC. 4 $79.74

By nature of payment

Food and Beverage
$3,520
Education
$19

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,535
Patients
346
Total drug cost
$78,021
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 551 104 $46,513
Methotrexate (Methotrexate Sodium) Brand 116 26 $5,562
Duloxetine Hcl Generic 108 22 $3,629
Prednisone Generic 107 50 $790
Meloxicam Generic 100 27 $406
Celecoxib Generic 96 26 $5,951
Allopurinol Generic 76 17 $783
Leflunomide Generic 74 19 $8,130
Gabapentin Generic 70 13 $796
Diclofenac Sodium Generic 53 16 $2,661

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Lindsay Kelmenson's medical specialty?
Dr. Lindsay Kelmenson practices Rheumatology Physician in Hoover, AL.
Where does Dr. Lindsay Kelmenson practice?
Dr. Lindsay Kelmenson practices at 5356 Stadium Trace Pkwy Ste 200, Hoover, AL 352445610. Office phone: 2054444858.
What is Dr. Lindsay Kelmenson's NPI?
Dr. Lindsay Kelmenson's National Provider Identifier (NPI) is 1457647935, issued by NPPES.
Does Dr. Lindsay Kelmenson accept Medicare assignment?
Yes. Dr. Lindsay Kelmenson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lindsay Kelmenson commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.